| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |